Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays

Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy; its early detection is critical for improving prognosis. Electrochemiluminescent-based multiplex immunoassays were developed with high analytical performance. All proteins were analyzed in sera of patients diagnosed with PDAC (n = 138),...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jin, Sokoll, Lori J., Chan, Daniel W., Zhang, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698985/
https://www.ncbi.nlm.nih.gov/pubmed/34944713
http://dx.doi.org/10.3390/biomedicines9121897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698985/
https://www.ncbi.nlm.nih.gov/pubmed/34944713
http://dx.doi.org/10.3390/biomedicines9121897

Ejemplares similares